A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistanceQiyao Zheng, Xiaolei Zhang, Jianshan Mo et al.|Theranostics|2020Cited by 110